Topic: Ba 2 86

The FDA authorized new COVID-19 booster shots from Pfizer and Moderna to target the latest strains, including the BA.2.86 variant. While national cases are not currently in a "worrisome wave," health officials are warning of a potential "winter wave." The discussion notes that the federal government will no longer pay for the shots, with costs shifting to private insurance and Medicare at approximately $120 per dose.

Health officials report an uptick in COVID-19 cases linked to the BA.2.86 variant, leading some hospitals to reinstate mask mandates. Dr. William Schaffner of Vanderbilt University recommends masking for high-risk individuals, while the CDC prepares for new booster shots. The discussion contrasts these reports with wastewater data showing declining trends in California and New York.

Former FDA Commissioner and Pfizer board member Dr. Scott Gottlieb appeared on CBS to discuss the "highly mutated" BA.2.86 variant. Gottlieb noted that while the variant is genetically distinct, it does not yet appear more pathogenic. He promoted the mid-September rollout of new boosters, which will be funded by the Biden administration's $5 billion "Project Next Gen." The vaccines are expected to be available for free at pharmacies and health departments by Halloween.